. 2022 Jun 8;38(6):e3549. doi: 10.1002/dmrr.3549

TABLE 1.

Baseline characteristics of participants

Study	Group	Number of patients randomised	Age (years)	Male %	Follow up (months)	Previous history of DFU %	Previous history of amputations %	Duration of DM in years	HbA1c %
Lavery et al. (2004) ¹³	Intervention	41 ^b	55.0 ± 9.3	49	6	41	2	14.8 ± 11.5	NR
Lavery et al. (2004) ¹³	Control	44 ^b	54.8 ± 9.6	52	6	41	2	12.7 ± 10.0	NR
Armstrong et al. (2007) ¹²	Intervention	111	68.2 ± 9.6	98	18	15	NR	13.6 ± 11.6	8.1 ± 1.9
Armstrong et al. (2007) ¹²	Control	114	69.7 ± 10.4	95	18	17	NR	12.6 ± 9.1	7.4 ± 1.4
Lavery et al. (2007) ¹⁵	Intervention	59	65.4 ± 9.3	56	15	100	22	12.7 ± 9.7	NR
Lavery et al. (2007) ¹⁵	Control	58	65.0 ± 9.6	53	15	100	31	13.7 ± 10.3	NR
Skafjeld et al. (2015) ¹⁴	Intervention	21	57.1 ± 10.2	86	12	100	33 ^c	17.0 (NR) ^a	8.3 ± 1.5
Skafjeld et al. (2015) ¹⁴	Control	20	59.4 ± 13.0	75	12	100	40 ^c	19.5 (NR) ^a	7.9 ± 1.7
Bus et al. (2021) ⁵	Intervention	151	65.0 ± 10.6	72	18	97	27	20 ± 14	7.7 ± 3.7
Bus et al. (2021) ⁵	Control	153	64.2 ± 10.5	73	18	97	26	21 ± 15	7.7 ± 3.6

Note: Data is shown as numbers or mean ± standard deviation or percentages unless otherwise highlighted. To convert percentage HbA1c values to mmol HbA1c per mol Hb use the following equation 10.93 × % hbA1c − 23.5 mmol/mol.

Abbreviations: DFU, diabetes‐associated foot ulcer; DM, diabetes mellitus; HbA1c, glycated haemoglobin; NR, not reported.

^{^a}

Data were reported as median (inter quartile range).

^{^b}

Based on the data presented in results in‐contrast to the numbers presented in the abstract.

^{^c}

Included participants with a history of toe amputations.